Breaking News

BREAKING: 22 U.S. Senate Democrats Want Answers from PhRMA About its Members’ 340B Actions

22 U.S. Senate Democrats Want Answers from PhRMA About its Members’ 340B Actions Twenty-two Democratic U.S. senators asked Pharmaceutical Research [...]

Continue Reading

Breaking News

BREAKING: House Democratic Committee Chairs Say Drug Companies’ Actions Could Put 340B on “Treacherous Path”

House Democratic Committee Chairs Say Drug Companies’ Actions Could Put 340B on “Treacherous Path” Letting drug manufacturers “pick and choose” [...]

Continue Reading

Breaking News

BREAKING: HRSA is Investigating Whether Manufacturer Policies to Restrict 340B Pricing at Contract Pharmacies Violates Statute

HRSA is Investigating Whether Manufacturer Policies to Restrict 340B Pricing at Contract Pharmacies Violates Statute In a major development, the [...]

Continue Reading

Breaking News

BREAKING: Kalderos Wants to Give Drug Manufacturers a Way to Pay 340B Rebates in Lieu of Discounts

Kalderos Wants to Give Drug Manufacturers a Way to Pay 340B Rebates in Lieu of Discounts Prescription drug information technology [...]

Continue Reading

Breaking News

BREAKING: AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy

AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy Drug manufacturer AstraZeneca today sent letters to 340B [...]

Continue Reading

Breaking News

BREAKING: Omnicell Buys PSG’s 340B Line of Business, the Latest in a Trend of 340B TPA Acquisitions

Omnicell Inc., a leading provider of automated drug dispensing systems and other prescription drug supply chain products and services, has [...]

Continue Reading
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live

Sliding Sidebar

Link to spotlight on Sean Hall of Visante

Article Archives